small-logo
ProfessionalsCapabilitiesInsights & NewsCareersLocations
About UsAlumniOpportunity & InclusionPro BonoCorporate Social Responsibility
Stay Connected:
facebookinstagramlinkedintwitteryoutube
  1. Professionals

T. Reed Stephens

Partner

Co-Chair, Health Care and Life Sciences Industry Group

Washington, DC

+1 202-282-5795

Let's Connect

Email
vCard
LinkedIn
  • Full Bio PDFPDF
    • Email
    • LinkedIn
    • Facebook
    • Twitter
    Share this page
  • Overview
  • Experience
  • Credentials
  • Insights & News

Reed is a nationally recognized legal authority in the life sciences industry, as well as the pharmaceutical fraud and abuse and corporate compliance spaces, and focuses his practice on fraud and abuse defense, corporate compliance, and risk management across the full spectrum of healthcare providers, managed care organizations, pharmaceutical manufacturers and medical device companies. He has extensive experience with the Anti-Kickback Statute and Stark Physician Self-Referral Law, and False Claims Act litigation.

Reed represents pharmaceutical and biotech manufacturers, wholesalers and individuals, health care systems, and non-health care-related companies in various global industries. This includes the defense industry, government contractors in the gaming industry, as well as the financial services and banking sectors. He has experience in matters involving state and federal government law enforcement and U.S. congressional investigations. He represents health systems and managed care organizations in federal False Claims Act litigation, and counsels pharmaceutical manufacturers on government drug pricing and voluntary disclosures in the areas of Medicaid Drug Rebate, Federal Supply Schedule/Department of Veterans Affairs, and the 340B program.

Furthermore, Reed advises his clients—including private equity sponsors—and provides employee training on risk management concerns involving mergers and acquisitions, post-merger integration compliance and disclosure of misconduct, public policy and legislative developments, supply chain disputes, and an array of regulatory compliance matters concerning product marketing and foreign anti-corruption statutes. He is a member of the firm's Videogame, Gaming and Esports Industry Group dedicated to providing comprehensive legal solutions to companies in this industry.

Previously, Reed was a Trial Attorney with the Civil Frauds Section within the U.S. Department of Justice Civil Division, where he led more than 60 federal False Claims Act investigations—the majority involving allegations of health care fraud perpetrated against various government agencies. Reed was lead counsel for the U.S. in the first successful government price reporting cases against the pharmaceutical industry, involving Medicare and Medicaid Average Wholesale Price reporting (US ex rel. Ven-A-Care v. et al.); Medicaid Drug Rebate price reporting (US ex rel. Foster v. Parke-Davis, US ex rel. Alcorn v. Schering-Plough); and the Prescription Drug Marketing Act fraud (US ex rel. Gerstein v. TAP Pharmaceuticals).

Key Matters

Some of the experience represented below may have been handled at a previous firm.

  • United States ex rel. Kunz v. Halifax Health, et al. – Obtained summary judgment for defendants on non-intervened False Claims Act allegations involving more than US$450M in alleged damages for Anti-Kickback Statute, Stark law and Medicare lack of medical necessity violations
  • United States ex rel. Bates and Patrick v. Kyphon, Inc.– Represented several health systems in the long-running Medicare short stay Kyphoplasty medical necessity False Claims Act qui tam
  • United States ex rel. Cortinas v. Midtown Imaging, LLC, et al. – Obtained favorable mediated resolution of False Claims Act Anti-Kickback allegations
  • Advised senior management and the board of directors of a global manufacturer in connection with whistleblower allegations of employee misconduct
  • Represented a major pharmaceutical manufacturer in a joint U.S. Senate and U.S House of Representatives congressional investigation of pharmaceutical product price increases
  • Represented several employees of a pharmaceutical manufacturer during federal grand jury proceedings in an Off Label Promotion civil/criminal investigation
  • Represented department head of an academic medical center during a federal criminal investigation of Anti-Kickback allegations against medical device company Olympus
  • Obtained declination and dismissal with prejudice of False Claims Act allegations of Medicare false billing assert against a national rehabilitation hospital chain
  • Represented a global U.S. defense contractor in connection with a voluntary disclosure to the U.S. Department of Defense of contract billing compliance concerns
  • Assisted a pharmaceutical manufacturer in achieving compliance with court-ordered remedial steps involving enhancements to corporate by-laws and regulatory affairs responsibilities triggered by a shareholder derivative case
  • Represented U.S. subsidiary of a global gaming company in connection with District of Columbia Office of Attorney General investigation of government contract compliance

  • The Best Lawyers in America®—Recognized for Health Care Law (2024–2025)
  • Benchmark Litigation—Recognized as a “D.C. Litigation Star” (2023–2024)
  • The Legal 500 US—Recognized for Dispute Resolution: Corporate Investigations and White Collar Criminal Defense (2021–2023)
  • The Legal 500 US—Recognized for Healthcare: Life Sciences and for Healthcare: Service Providers (2021–2024)
  • Chambers USA—Ranked for Health Care (2008–2014)
  • LMG Life Sciences—Recognized (2012–2016, 2018, 2021, 2022)
  • Benchmark Litigation—Recognized (2016–2019)
  • Savoy Magazine—“Most Influential Black Lawyers” (2015)
  • On Being a Black Lawyer—“Nation’s Top Lobbyists & Influencers” (2014)
  • Washingtonian Magazine—“Washington’s Best Lawyers for Health Care” (2013)
  • Nightingale’s Healthcare News—“Outstanding Healthcare Litigators” (2006)
  • U.S. Department of Justice— Civil Division’s “Special Commendation Award for Outstanding Service” (2002)
  • U.S. Department of Justice— “Meritorious Service Award” (2000)

  • American Bar Association, Health Law Section
  • American Health Lawyers Association
  • Law360 Life Sciences Editorial Advisory Board (2022 & 2023) 
  • American Inns of Court, Edward Bennett Williams Chapter, Washington, D.C.
  • President’s Commission on White House Fellowships, Regional Interviewer of White House Fellow Candidates, 2015
  • D.C. Bar Association
  • Norwood School in Bethesda, Maryland – served two three-year terms on the board of trustees

Capabilities

Government Program Fraud, False Claims Act & Qui Tam Litigation
Insurance Litigation
Life Sciences
Health Care
Medical Devices
Insurance

Key Matters

Some of the experience represented below may have been handled at a previous firm.

  • United States ex rel. Kunz v. Halifax Health, et al. – Obtained summary judgment for defendants on non-intervened False Claims Act allegations involving more than US$450M in alleged damages for Anti-Kickback Statute, Stark law and Medicare lack of medical necessity violations
  • United States ex rel. Bates and Patrick v. Kyphon, Inc.– Represented several health systems in the long-running Medicare short stay Kyphoplasty medical necessity False Claims Act qui tam
  • United States ex rel. Cortinas v. Midtown Imaging, LLC, et al. – Obtained favorable mediated resolution of False Claims Act Anti-Kickback allegations
  • Advised senior management and the board of directors of a global manufacturer in connection with whistleblower allegations of employee misconduct
  • Represented a major pharmaceutical manufacturer in a joint U.S. Senate and U.S House of Representatives congressional investigation of pharmaceutical product price increases
  • Represented several employees of a pharmaceutical manufacturer during federal grand jury proceedings in an Off Label Promotion civil/criminal investigation
  • Represented department head of an academic medical center during a federal criminal investigation of Anti-Kickback allegations against medical device company Olympus
  • Obtained declination and dismissal with prejudice of False Claims Act allegations of Medicare false billing assert against a national rehabilitation hospital chain
  • Represented a global U.S. defense contractor in connection with a voluntary disclosure to the U.S. Department of Defense of contract billing compliance concerns
  • Assisted a pharmaceutical manufacturer in achieving compliance with court-ordered remedial steps involving enhancements to corporate by-laws and regulatory affairs responsibilities triggered by a shareholder derivative case
  • Represented U.S. subsidiary of a global gaming company in connection with District of Columbia Office of Attorney General investigation of government contract compliance

Credentials

Education

Reed received his J.D. from Stanford Law School in 1991, where he served on the articles board of the Stanford Law Review. He received his B.A. from Princeton University in 1988.

    Admissions
    • District of Columbia
    Clerkships
    • USDC - Eastern District of PA for the Honorable Clifford Scott Green
    • USDC - Eastern District of PA for the Honorable Clifford Scott Green

    Related Insights & News

    Speaking Engagements
    • "Life Sciences 2024: Navigating Legal Challenges in Drug and Device Industries," Practising Law Institute, Panelist, September 19, 2024
    • "Healthcare Fraud: It's Always Been About Healthcare. It Will Always Be About Healthcare. So What's the News?" American Bar Association, 2024 Civil False Claims Conference, Moderator, June 5, 2024
    Seminar/CLE
    2025 Health Care & Life Sciences Summit

    May 13, 2025

    Client Alert
    White House Memorandum Elaborates on Prior Executive Order with Requirements for “High-Impact AI” Used by Federal Agencies

    May 2, 2025

    Client Alert
    April 2025 Executive Order Targets Prescription Drug Price Reduction

    May 1, 2025

    Blog
    Federal Jury Finds No Liability for SuperValu in FCA Case Remanded for Trial by SCOTUS

    April 2, 2025

    Client Alert
    HHS Announces Major Restructuring and Workforce Reductions

    March 28, 2025

    Sponsorship
    Winston & Strawn Sponsors Healthcare Business International 2025

    March 24, 2025

    Client Alert
    CMS Announces Early Termination of Four Medicare Payment Models

    March 19, 2025

    Blog
    First Circuit Joins Circuit Split in Favor of “But For” Causation Required To Show Falsity in AKS-Based False Claims Act Cases

    March 13, 2025

    Client Alert
    Current Status of White House Executive Order on Gender-Affirming Care

    March 5, 2025

    Client Alert
    Executive Order Reemphasizes Healthcare Price Transparency

    March 4, 2025

    Client Alert
    National Institutes of Health Newly Disseminated Guidance on Charging of Indirect Grant Costs

    February 24, 2025

    Client Alert
    Executive Order Calls for the Second Withdrawal of the United States from the World Health Organization

    February 10, 2025

    View All Insights & News

    Capabilities

    Government Program Fraud, False Claims Act & Qui Tam Litigation
    Insurance Litigation
    Life Sciences
    Health Care
    Medical Devices
    Insurance
    Logo
    facebookinstagramlinkedintwitteryoutube

    Copyright © 2025. Winston & Strawn LLP

    AlumniCorporate Transparency Act Task ForceDEI Compliance Task ForceEqual Rights AmendmentLaw GlossaryThe Oval UpdateWinston MinutePrivacy PolicyCookie PolicyFraud & Scam AlertsNoticesSubscribeAttorney Advertising